Use of the Gait Deviation Index for the Evaluation of Patients With Parkinson's Disease

ABSTRACT The authors aimed to determine whether the Gait Deviation Index (GDI) could be feasible to characterize gait in patients with Parkinson's disease (PD) and evaluate outcomes of levodopa treatment. Twenty-two PD participants were evaluated with clinical examination and 3-D quantitative gait analysis (GDI was calculated from gait analysis) in 2 states (OFF and ON) after taking levodopa. Twenty age-matched healthy participants (CG) were included as controls. The GDI value in the OFF state was 83.4 ± 11.5 (statistically different from CG) while clinical scales demonstrated a moderate–severe gait impairment of these patients. Significant improvements are evident from clinical scores and by GDI values in the ON state. The mean GDI for the ON state (GDION: 87.9 ± 10.4) was significantly higher than in for the OFF state (GDIOFF: 83.4 ± 11.5), indicating a global gait improvement after the treatment. The results show that GDI has lower value as an indicator of pathology in PD patients than in quantifying the effects of levodopa treatment in PD state.

[1]  Behrooz Sepehri,et al.  Quantification of Rigidity in Parkinson’s Disease , 2007, Annals of Biomedical Engineering.

[2]  Adrian Lees,et al.  Visualisation of gait data with Kohonen self-organising neural maps. , 2006, Gait & posture.

[3]  D. Jennings,et al.  The natural history of the syndrome of primary progressive freezing gait. , 2002, Archives of neurology.

[4]  C. Granger,et al.  The functional independence measure: a new tool for rehabilitation. , 1987, Advances in clinical rehabilitation.

[5]  Maureen Tingley,et al.  An index to quantify normality of gait in young children. , 2002, Gait & posture.

[6]  A J Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study , 2001, Neurology.

[7]  R. Baker,et al.  Correlations of the Gait Profile Score and the Movement Analysis Profile relative to clinical judgments. , 2009, Gait & posture.

[8]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[9]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[10]  L. Schutte,et al.  An index for quantifying deviations from normal gait. , 2000, Gait & posture.

[11]  M. Morris,et al.  Three‐dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder , 2005, Movement disorders : official journal of the Movement Disorder Society.

[12]  Joyce P Trost,et al.  A tool for quantifying hip flexor function during gait. , 2000, Gait & posture.

[13]  B C McDowell,et al.  Further evidence of validity of the Gait Deviation Index. , 2010, Gait & posture.

[14]  R. B. Davis,et al.  A gait analysis data collection and reduction technique , 1991 .

[15]  Michael H Schwartz,et al.  The Gait Deviation Index: a new comprehensive index of gait pathology. , 2008, Gait & posture.

[16]  Adam Rozumalski,et al.  The gait profile score and movement analysis profile. , 2009, Gait & posture.

[17]  M. Morris,et al.  Constraints on the kinetic, kinematic and spatiotemporal parameters of gait in Parkinson's disease , 1999 .

[18]  M. Morris,et al.  The biomechanics and motor control of gait in Parkinson disease. , 2001, Clinical biomechanics.

[19]  J. Gracies,et al.  Long-term monitoring of gait in Parkinson's disease. , 2007, Gait & posture.

[20]  Adrian Lees,et al.  Gait quality assessment using self-organising artificial neural networks. , 2007, Gait & posture.

[21]  M Crivellini,et al.  Use of the normalcy index for the evaluation of gait pathology. , 2004, Gait & posture.